Strategy for repeat prostate biopsy: Predictors of positive biopsy and additional biopsy location

Urologia Internationalis

Volumn 81, Issue 2, 2008, Pages 173-178

  Katto, Kazunobu ^a   Takahashi, Masayuki ^a   Taue, Ryuichi ^a   Nakatsuji, Hiroyoshi ^a   Kishimoto, Tomoteru ^a   Izaki, Hirofumi ^a   Oka, Natsuo ^a   Fukumori, Tomoharu ^a   Nishitani, Masa Aki ^a   Kanayama, Hiro Omi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Biopsy location; Prostate cancer; Radical prostatectomy; Repeat biopsy

Indexed keywords

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REPEAT BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR LOCALIZATION;

BIOPSY, NEEDLE; FORECASTING; HUMANS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REOPERATION;

EID: 50849132871     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000144056     Document Type: Article

References (20)

1. Hodge KK, McNeal JE, Terris MK, Stamy TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-75.
2. Brawer MK: Prostate-specific antigen: current status. CA Cancer J Clin 1999;49:264-281.
3. Kanayama HO, Kagawa S, Utsunomiya M, Kawashima S, Takehisa I: Mass screening for prostate cancer in Tokushima City: the result of 2001. Nippon Hinyokika Gakkai Zasshi 2004;95:596-603.
4. Kinoshita H, Ogawa O: Prostate cancer incidence, mortality, and survival rates in Japan. Nippon Rinsho 2001;59:364-372.
5. Stroumbakis N, Cookson MS, Reuter VE, Fair WR: Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology 1997;49:113-118.
6. Epstein JI, Walsh PC, Sauvageot J, Carter HB: Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol 1997;158:1886-1890.
7. Stamatiou K, Alevizos A, Karanasiou V, Mariolis A, Mihas C, Papathanasiou M, Bovis K, Sofras F: Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer. Urol Int 2007;78:313-317.
8. Thiesler T, Trinkler F, Horcic M, Willi N, Cathomas G, Hailemariam S: Patients with low prostate-specific antigen levels (< 4 ng/ mg) would benefit from a twelve-core biopsy protocol for prostate cancer detection. Urol Int 2007;78:318-322.
9. Takashima R, Egawa S, Kuwao S, Baba S: Anterior distribution of stage T1c nonpalpable tumors in radical prostatectomy specimens. Urology 2002;59:692-697.
10. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P: Detailed mapping of prostate carcinoma foci. Cancer 2000;89:1800-1809.
11. Stamey TA: Marking the most out of six systematic sextant biopsies. Urology 1995;45:2-12.
12. Terris MK, Wallen EM, Stamey TA: Comparison of mid-lobe versus lateral systematic sextant method for the diagnosing carcinoma of the prostate. Urol Int 1997;59:239-242.
13. Eskew LA, Bare RL, McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-203.
14. Fleshner NE, O'Sullivan M, Fair WR: Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 1997;158:505-509.
15. Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans P: A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000;163:152-157.
16. Chan DW, Sokoll LJ, Partin AW, Wong PT, Sasse E, Montie J: The use of % free PSA(%PSA) to predict prostate cancer probabilities: an eleven center prospective study using an automated immunoassay system in a population with non-suspicious DRE. J Urol 1999;161:95.
17. Djavan B, Ravery V, Zotta A, Dobronski P, Dobrovits M, Fakhari M: Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 2001;166:1679-1683.
18. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A: Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. JAMA 1998;279:1542-1547.
19. Fowler JE Jr, Bigler SA, Miles D, Yalkut DA: Predictor of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol 2000;163:813-818.
20. Villamón-Fort R, Martinez-Jabaloyas J, Soriano-SarriáP, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M: Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy. Urol Int 2007;78:328-333.